Literature DB >> 19193293

Time from illness onset to death, 1918 influenza and pneumococcal pneumonia.

Keith P Klugman, Christina Mills Astley, Marc Lipsitch.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19193293      PMCID: PMC2657896          DOI: 10.3201/eid1502.081208

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Brundage and Shanks () have studied time to death from the onset of influenza symptoms during the 1918 pandemic in military and civilian populations and found a median time to death of 7–11 days. They argue that these data support the idea that the deaths may be predominantly due to bacterial superinfection after the acute phase of influenza. We observed a similar 10-day median time to death among soldiers dying of influenza in 1918 (), a finding consistent with the time to death for a bacterial superinfection, specifically pneumococcal bacteremic pneumonia (). The major bacterial pathogen associated with influenza-related pneumonia in 1918 was Streptococcus pneumoniae (,). Neither antimicrobial drugs nor serum therapy was available for treatment in 1918. To further analyze the time course of death from influenza in relation to that of pneumococcal pneumonia in 1918, we examined data collected by Tilghman and Finland () from the pre–antimicrobial drug era of the 1920s and 1930s. The Figure shows the distribution of time from onset of illness to death due to influenza-related pneumonia in 1918 compared with time to death due to untreated pneumococcal pneumonia in the 1920s and 1930s. The Figure indicates a close concordance of the times to death. Similar times to death do not prove the specific bacterial etiology of the 1918 deaths. However, pneumococcal bacteremia was associated with most of the pneumonia deaths reported by Tilghman and Finland (), and most 1918 influenza-related deaths were due to bacterial pneumonia (). Also, up to 50% of patients dying from pneumonia in 1918 had pneumococcal bacteremia (). These similar times to death provide additional evidence that the influenza-related pneumonia deaths during the 1918 influenza pandemic were largely due to the pneumococcus.
Figure

Distribution of days of illness before death from influenza-related pneumonia, 1918, and from untreated pneumococcal pneumonia, 1920s and 1930s.

Distribution of days of illness before death from influenza-related pneumonia, 1918, and from untreated pneumococcal pneumonia, 1920s and 1930s.
  4 in total

1.  Pneumococcal vaccines and flu preparedness.

Authors:  Keith P Klugman; Shabir A Madhi
Journal:  Science       Date:  2007-04-06       Impact factor: 47.728

2.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

3.  Transmissibility of 1918 pandemic influenza.

Authors:  Christina E Mills; James M Robins; Marc Lipsitch
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

4.  Deaths from bacterial pneumonia during 1918-19 influenza pandemic.

Authors:  John F Brundage; G Dennis Shanks
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

  4 in total
  16 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

Review 3.  Pandemic influenza: certain uncertainties.

Authors:  David M Morens; Jeffery K Taubenberger
Journal:  Rev Med Virol       Date:  2011-06-27       Impact factor: 6.989

4.  Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.

Authors:  Yuet Wu; Wenwei Tu; Kwok-Tai Lam; Kin-Hung Chow; Pak-Leung Ho; Yi Guan; Joseph S Malik Peiris; Yu-Lung Lau
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

5.  Free actin impairs macrophage bacterial defenses via scavenger receptor MARCO interaction with reversal by plasma gelsolin.

Authors:  Christine M Ordija; Terry Ting-Yu Chiou; Zhiping Yang; Glen M Deloid; Melina de Oliveira Valdo; Zhi Wang; Alice Bedugnis; Terry L Noah; Samuel Jones; Henry Koziel; Lester Kobzik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-06       Impact factor: 5.464

6.  Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  Epidemics       Date:  2009-09       Impact factor: 4.396

Review 7.  Threats of antibiotic resistance: an obliged reappraisal.

Authors:  Fernando Baquero
Journal:  Int Microbiol       Date:  2021-05-24       Impact factor: 2.479

8.  Influenza infectious dose may explain the high mortality of the second and third wave of 1918-1919 influenza pandemic.

Authors:  A Cristina Paulo; Margarida Correia-Neves; Tiago Domingos; Alberto G Murta; Jorge Pedrosa
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

9.  Spatial dynamics of the 1918 influenza pandemic in England, Wales and the United States.

Authors:  Rosalind M Eggo; Simon Cauchemez; Neil M Ferguson
Journal:  J R Soc Interface       Date:  2010-06-23       Impact factor: 4.118

10.  Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture.

Authors:  John S Sullivan; Paul W Selleck; Teena Downton; Ingrid Boehm; Anna-Maree Axell; Yasmin Ayob; Natalie M Kapitza; Wayne Dyer; Anna Fitzgerald; Bradley Walsh; Garry W Lynch
Journal:  J Mol Genet Med       Date:  2009-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.